Established 1999
 
8,000 companies from
USA,Canada and India.
 
   
Search over 25,000 News & Earnings Archives    
 

Polypore International, Inc.(PPO)

 
123Jump Rating: - Short-Term Growth   Underwriters: J. P. Morgan & Co.
      Credit Suisse First Boston
Status: Priced  
 
Address: 11430 North Community House Road, Ste.350
FiledDate: 03/14/2007
  Charlotte,
   
  NC 28277
Filed Price Range ($): $22.00
       
Telephone: 704- 587-8409 Filed Offer Amount ($ Million): $379.50
       
Fax: www.polypore.net Shares Offered (Millions): 15
       
Websites: Shares Outstanding (Millions): 40.30
       
Management: Robert Toth, Pres./CEO/Dir.
IPO Date: 06/27/2007
  Lynn Amos, CFO/Treasurer
   
  John O'Malley, SVP
Final Offer Price ($): $19.00
       
Industry: Manufacturer Final Offer Size (Millions of Shares): 15.00
       
Employees: 1,800 Final Offer Amount ($ Million): $285.00
       
Competitors: Entek
S-1 Forms:
  Nippon Sheet Glass, Co., Ltd.
   
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Investor Relations Corporate / History Profile Executives Products Services
Quarterly Performance   

Qtr Ended

Revenues Net Income EPS
03 / 2002 65,056 4,711 8.42
06 / 2002 94,765 5,186 33.28
09 / 2002 90,816 4,715 30.03
12 / 2002 94,795 2,234 12.71
03 / 2003 102,502 8,529 53.06
06 / 2003 107,516 7,858 48.74
09 / 2003 108,996 11,313 70.89
01 / 2004 122,062 17,613 111.37
Major Stock Holders   (Prior To Offering)

Name

Class A
David A. Barr 100.00%
Kevin Kruse 100.00%
Michael Graff 100.00%
Warburg Pincus International Partners, L.P 91.30%
Warburg Pincus Private Equity VIII, L.P 91.30%

Business Environment

The global market for separation and filtration membranes is large and extremely fragmented, with most suppliers producing products for separate and distinct niches. Industry analysts estimate that the annual global market for lead-acid batteries is approximately $30 billion, or 770 million units, of which approximately $25 billion, or 600 million units, are lead-acid batteries for SLI applications for motor vehicles. Accordingly, the size of the separator market is much smaller than the overall lead-acid battery market. The SLI lead-acid battery market is characterized by stable demand because of the relatively short replacement cycle for batteries in automobiles. The primary demand driver of the replacement market is the size of the worldwide fleet of motor vehicles, which, according to Ward\'s Motor Vehicles Facts and Figures, has been growing approximately 3% per year. Secondary drivers of the replacement market include weather patterns (hot summers and cold winters tend to shorten battery life), the longer average life of vehicles and the larger average size of engines.

According to industry analysts, the market for rechargeable lithium batteries used in electronic devices is over $3 billion and the market for disposable lithium batteries is approximately $700 million. As with lead-acid batteries, the size of the market for separators is considerably smaller than the overall market for lithium batteries. According to industry analysts, sales in the rechargeable lithium battery market grew at a compound annual growth rate of approximately 22% from 1996 to 2001 and are expected to grow at a compound annual growth rate of approximately 16% through 2011. Growth in the rechargeable lithium battery business has historically been driven by growth in the underlying markets for portable electronic products (primarily mobile phones and laptop computers) and the displacement of nickel-based battery technologies. The continuing market growth is being driven by the increasing mobility of consumers demanding portable electronic devices, the increasing number of consumers purchasing back-up batteries, and the increasing functionality and complexity of these devices requiring more battery power and more batteries per electronic device. Lithium-based batteries exhibit superior energy density and weight characteristics relative to other battery technologies such as nickel-based materials and have become the standard in the majority of consumer end-markets.

Company Strategy
The Company is a leading worldwide developer, manufacturer and marketer of highly specialized polymer-based membranes used in separation and filtration processes in terms of market share.

Product/Services Portfolio
The Company develops, manufactures and markets a complete line of polyethylene and other resin separators for use in lead-acid batteries. Approximately 80% of the lead-acid battery separators the Company sells are used in SLI batteries for automobiles and other motor vehicles and approximately 20% are used in batteries for industrial applications such as forklifts, marine applications and stationary applications such as backup power for telecom infrastructure and uninterruptable power supply systems.

The Company also develops, manufactures and markets a complete line of polypropylene and polyethylene monolayer and proprietary multilayer separators used for rechargeable (Li2) and disposable (Li1) lithium batteries. Approximately 80% of the lithium battery separators the Company sells are used in rechargeable lithium batteries and 20% are used for disposable lithium batteries.

The Company is a leading developer, manufacturer and marketer of membranes for use in blood oxygenators, with an estimated 85% global market share. A blood oxygenator is a device containing highly specialized separation media used to remove carbon dioxide from the blood while oxygen is diffused through the membrane and into the blood. Oxygenators are primarily sold to hospitals for use in heart-lung bypass surgical procedures.

The Company is a leading developer, manufacturer and marketer of extracorporeal therapeutic plasmapheresis membranes, with an estimated 57% market share. Plasmapheresis is the extracorporeal separation of blood cells and plasma from plasma proteins in different diseases. Therapeutic plasmapheresis is a new and growing field that is becoming accepted among the medical community

The Company develops, manufactures and markets a number of industrial and specialty filtration and filtration-related products. Liquid filtration is a diverse and high growth market. Almost every process stream has a filtration application. The Company has leveraged its established filtration technology and membrane expertise to supply a broad portfolio of membranes based on flat sheet, tubular and capillary technology.

The Company has also developed significant capability in the development of membrane applications for fuel cells. The Company has leveraged its technological expertise in electrochemistry and has established key technical alliances to develop membrane technology for fuel cell applications. The Company has already developed several functional membranes for controlling moisture in fuel cell systems.

Investment Analysis
Net sales for the three-month period ended April 3, 2004 were $140.1 million, an increase of $37.6 million, or 36.7%, from the three-month period ended March 29, 2003.

Gross profit for the three months ended April 3, 2004 was $53.8 million, an increase of $19.6 million, or 57.3%, from the three months ended March 29, 2003.

Selling, general and administrative expenses for the three months ended April 3, 2004 were $19.0 million, an increase of $3.2 million, or 20.3%, from the three months ended March 29, 2003.

Interest expense, net was $4.5 million for the three months ended April 3, 2004 and March 29, 2003.

Income tax expense as a percentage of income before income taxes was 34.1% for the three months ended April 3, 2004, as compared to the 40.1% effective tax rate for the three months ended March 29, 2003.

Income Data (Thousand $ Except EPS)
Year Revenues Costs Oper Income Taxes Net Income EPS
2001 245,718 18,189 57,821 16,003 22,430 152.40
2002 345,432 24,949 53,183 11,388 16,846 84.18
2003 441,076 21,667 85,761 18,781 45,313 284.06
2005 432,504 0.00 66,002 -8,626 -2,942 -17.16
2006 479,677 0.00 40,014 -23,087 -29,569 -172.21
*As of period Ended December 28, 2002
*As of period Ended January 3, 2004

Balance Sheet Data (Thousand $)

Year

Cash Acct Recv. Inventory Total Cur Assets Total Cur Liability PPE Total Assets LT Debt SH Equity
2002 24,606 67,647 47,533 150,670 97,694 424,082 633,145 276,070 97,585
2003 20,063 89,471 60,941 181,938 100,988 480,602 730,642 250,519 189,757
2005 28,060 88,347 60,539 185,981 62,847 370,871 1,364,576 0.00 93,332
2006 54,712 102,110 67,741 237,949 90,381 363,526 1,389,860 0.00 69,662
*As of period Ended January 3, 2004

Cash Flow Summary (Thousand $)

Year

Net Cash-Ops Net Cash-Inv Net Cash-Fin Net Change
2001 29,403 -36,517 3,917 -2,982
2002 83,470 -141,409 83,051 11,066
2003 56,471 -33,797 -28,329 -4,543
2005 64,189 -12,993 -52,789 -5,089
2006 49,965 -23,912 -3,049 26,652
*As of period Ended December 28, 2002
*As of period Ended January 3, 2004
 

 


350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries

© 1999-2008 123jump.com. All rights reserved